Drdo Drug
- All
- News
- Videos
-
Critical Drug Developed Using DRDO Technology Gets Regulator's Approval
A critical drug developed on a DRDO technology for radiological and nuclear emergencies has received approval from the Drugs Controller General of India (DCGI), the defence ministry said on Tuesday.
-
India-Made Drug Shown To Treat Heart Damage Caused By Covid Protein: Study
A drug developed by the Defence Research and Development Organisation (DRDO) may reverse the heart damage caused by a protein in the SARS-CoV-2 virus, a study conducted in fruit flies and mice has found.
-
BDR Pharma Gets DRDO Nod To Manufacture, Sell Covid Drug 2-DG In India
BDR Pharma on Monday said it has inked a licensing pact with the Defence Research and Development Organisation (DRDO) to manufacture, distribute, and market COVID-19 drug 2-Deoxy-D-Glucose (2-DG) in the country.
-
Mankind Pharma Gets DRDO Nod To Manufacture, Sell Covid Drug 2-DG
Drug firm Mankind Pharma today said it has received licence from the Defence Research and Development Organisation (DRDO) to manufacture and market oral 2-deoxy-D-glucose (2-DG), used for the treatment of COVID-19.
-
DRDO Invites Applications From Indian Pharma Firms For Bulk Production Of Covid Drug 2-DG
The Defence Research and Development Organisation or DRDO, which developed 2-Deoxy-D-Glucose (2-DG), a drug used for treatment of COVID-19 patients, has called for Expression of Interest to transfer the technology to Indian pharmaceutical firms.
-
Rs 990 Per Sachet For Defence Research Body's Covid Drug '2-DG': Report
The price of a drug for COVID-19 patients developed by India's top defence research body has been fixed at Rs 990 per sachet, news agency ANI reported today quoting unnamed officials.
-
10,000 Sachets Of DRDO's Covid Drug To Hit Market Today, Says Rajnath Singh
Union Defence Minister Rajnath Singh informed that 10,000 sachets of anti-COVID drug 2-DG will be available in the market from Thursday. The anti-COVID drug has been developed by the Defence Research and Development Organisation (DRDO).
-
Assam Chief Minister Praises DRDO Scientist For Developing Anti-Covid Drug
Assam Chief Minister Himanta Biswa Sarma congratulated Dr Jubilee Purkayastha, a scientist with the Institute of Nuclear Medicine and Allied Sciences, for her outstanding contributions in the development of an anti-Covid drug.
-
Data Suggests Phase-3 Trials For Covid Drug 2-DG May Continue Till August
With the government presenting DRDO-developed drug 2-DG as a potential game-changer in the fight against COVID-19, the clinical trial registry data suggests that the phase-3 trials for the medicine at over two dozen government and private hospitals
-
Delhi Lt Governor Orders Availability Of Drug Related To Black Fungus: Report
Delhi's Lt Governor Anil Baijal today directed authorities to take immediate steps to ensure the availability of drugs related to black fungus and the newly launched D-2G for people in genuine and medically prescribed need, according to sources.
-
Critical Drug Developed Using DRDO Technology Gets Regulator's Approval
A critical drug developed on a DRDO technology for radiological and nuclear emergencies has received approval from the Drugs Controller General of India (DCGI), the defence ministry said on Tuesday.
-
India-Made Drug Shown To Treat Heart Damage Caused By Covid Protein: Study
A drug developed by the Defence Research and Development Organisation (DRDO) may reverse the heart damage caused by a protein in the SARS-CoV-2 virus, a study conducted in fruit flies and mice has found.
-
BDR Pharma Gets DRDO Nod To Manufacture, Sell Covid Drug 2-DG In India
BDR Pharma on Monday said it has inked a licensing pact with the Defence Research and Development Organisation (DRDO) to manufacture, distribute, and market COVID-19 drug 2-Deoxy-D-Glucose (2-DG) in the country.
-
Mankind Pharma Gets DRDO Nod To Manufacture, Sell Covid Drug 2-DG
Drug firm Mankind Pharma today said it has received licence from the Defence Research and Development Organisation (DRDO) to manufacture and market oral 2-deoxy-D-glucose (2-DG), used for the treatment of COVID-19.
-
DRDO Invites Applications From Indian Pharma Firms For Bulk Production Of Covid Drug 2-DG
The Defence Research and Development Organisation or DRDO, which developed 2-Deoxy-D-Glucose (2-DG), a drug used for treatment of COVID-19 patients, has called for Expression of Interest to transfer the technology to Indian pharmaceutical firms.
-
Rs 990 Per Sachet For Defence Research Body's Covid Drug '2-DG': Report
The price of a drug for COVID-19 patients developed by India's top defence research body has been fixed at Rs 990 per sachet, news agency ANI reported today quoting unnamed officials.
-
10,000 Sachets Of DRDO's Covid Drug To Hit Market Today, Says Rajnath Singh
Union Defence Minister Rajnath Singh informed that 10,000 sachets of anti-COVID drug 2-DG will be available in the market from Thursday. The anti-COVID drug has been developed by the Defence Research and Development Organisation (DRDO).
-
Assam Chief Minister Praises DRDO Scientist For Developing Anti-Covid Drug
Assam Chief Minister Himanta Biswa Sarma congratulated Dr Jubilee Purkayastha, a scientist with the Institute of Nuclear Medicine and Allied Sciences, for her outstanding contributions in the development of an anti-Covid drug.
-
Data Suggests Phase-3 Trials For Covid Drug 2-DG May Continue Till August
With the government presenting DRDO-developed drug 2-DG as a potential game-changer in the fight against COVID-19, the clinical trial registry data suggests that the phase-3 trials for the medicine at over two dozen government and private hospitals
-
Delhi Lt Governor Orders Availability Of Drug Related To Black Fungus: Report
Delhi's Lt Governor Anil Baijal today directed authorities to take immediate steps to ensure the availability of drugs related to black fungus and the newly launched D-2G for people in genuine and medically prescribed need, according to sources.
